Skip to main content

Table 2 Comorbidities and factors associated with neurological listeriosis - Univariate logistic analysis

From: Comorbidities and factors associated with central nervous system infections and death in non-perinatal listeriosis: a clinical case series

  Neurological listeriosis (n = 29) Not Neurological listeriosis (n = 35)  
  N % N % OR 95 % CI
Monotherapy (n = 57) 11 42.3 23 71.9 0.31 0.10-0.93**
Male 14 48.3 20 57.1 0.70 0.26-1.88
Saint Luc hospital 23 79.3 29 82.9 0.79 0.27-2.79
Diabetes mellitus 2 6.9 6 17.1 0.36 0.07-1.93
Immunosuppressive therapy 12 41.4 22 62.9 0.42 0.15-1.14
Cancer 11 37.9 11 31.4 1.33 0.47-3.76
Alcoholism 1 3.4 2 5.7 0.59 0.05-6.85
Renal disease 4 13.8 13 37.1 0.27 0.08-0.95**
HIV infection 2 6.9 4 11.4 0.57 0.10-3.38
Transplantation 3 10.3 9 25.7 0.33 0.08-1.37
Severe cardiovascular disease 6 20.7 13 37.1 0.44 0.14-1.37
Hepatic disease 3 10.3 8 22.9 0.40 0.09-1.63
Auto-immune disease 1 3.4 4 11.4 0.28 0.03-2.63
Immunocompromised status 16 55.2 25 71.4 0.49 0.18-1.38
  Mean SD Mean SD OR 95 % CI
Age in years at admission 57.6 19.5 60.6 19.1 0.99 0.97-1.02
BMI (n = 33) 23.6 5.6 24.8 5.3 0.96 0.83-1.10
Systole at admission (mmHg) (n = 55) 129.2 32.9 123.3 30.2 1.01 0.99-1.03
Diastole at admission (mmHg) 75.0 12.1 70.8 19.1 1.02 0.98-1.05
% neutrophil in blood at admission (n = 41) 74.1 25.3 74.0 19.1 1.00 0.97-1.03
% lymphocytes in blood at admission (n = 37) 15.5 17.6 14.0 9.3 1.01 0.96-1.06
CRP mg/dl at admission (n = 47) 31.9 33.5 34.2 18.3 0.10 0.99-1.01
Creatinine in blood at admission mg/L (n = 60) 2.8 3.0 4.6 9.9 0.96 0.86-1.06
Blood platelets at admission/L (103) (n = 56) 209.8 95.4 254.8 372.0 1.00 0.99-1.00
  Median Range Median Range OR 95 % CI
% neutrophil in CSF (n = 20) 71.5 35.0-94.0 79.0 8.5-94.6 1.00 0.96-1.04
% lymphocytes in CSF (n = 8) 40.0 2.0-88.0 / / / /
Glucose in CSF (mg/dL) (n = 10) 31.0 0.4-74.0 / / / /
Protein in CSF (mg/L) (n = 14) 164.5 27.0-732.0 / / / /
Admission year 1998 1983-2013 2006 1978-2014 0.95 0.90-1.02
  1. **p-value < 0.05